Immunocore Holdings plc
IMCR
$28.38
-$1.67-5.54%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 84.05M | 80.25M | 75.40M | 70.50M | 70.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 84.05M | 80.25M | 75.40M | 70.50M | 70.16M |
| Cost of Revenue | -147.23M | 51.40M | 52.78M | 57.71M | -106.06M |
| Gross Profit | 231.28M | 28.85M | 22.62M | 12.80M | 176.22M |
| SG&A Expenses | 42.32M | 35.53M | 38.64M | 39.29M | 41.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -18.05M | -- | -- | -- | 897.00K |
| Total Operating Expenses | 85.45M | 88.75M | 91.42M | 96.99M | 88.11M |
| Operating Income | -1.40M | -8.50M | -16.02M | -26.49M | -17.95M |
| Income Before Tax | -24.82M | 6.09M | -10.13M | -24.08M | -25.64M |
| Income Tax Expenses | -1.05M | -2.64M | 1.49M | 357.00K | -5.91M |
| Earnings from Continuing Operations | -23.77M | 8.74M | -11.62M | -24.44M | -19.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.77M | 8.74M | -11.62M | -24.44M | -19.73M |
| EBIT | -1.40M | -8.50M | -16.02M | -26.49M | -17.95M |
| EBITDA | -235.00K | -7.47M | -15.03M | -25.48M | -16.92M |
| EPS Basic | -0.48 | 0.17 | -0.23 | -0.49 | -0.40 |
| Normalized Basic EPS | -0.26 | 0.08 | -0.13 | -0.30 | -0.32 |
| EPS Diluted | -0.48 | 0.17 | -0.23 | -0.49 | -0.40 |
| Normalized Diluted EPS | -0.26 | 0.07 | -0.13 | -0.30 | -0.32 |
| Average Basic Shares Outstanding | 50.05M | 50.02M | 50.01M | 49.88M | 49.53M |
| Average Diluted Shares Outstanding | 50.05M | 52.81M | 50.01M | 49.88M | 49.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
